Skip to content

Drug interactions

Anagrelide + Osimertinib

Severity: Major

Anagrelide and Osimertinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Osimertinib can prolong the QTc interval, and anagrelide may add to it. The combination may raise the risk of arrhythmia, particularly in patients with cardiac disease or electrolyte abnormalities.

What this interaction means in plain words

Anagrelide and Osimertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Anagrelide belongs to Cardiovascular; Osimertinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid if feasible. If used together, obtain periodic ECGs and electrolytes and correct abnormalities.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Osimertinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Anagrelide with Osimertinib?

MediHelp rates the interaction as major. Anagrelide and Osimertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Osimertinib can prolong the QTc interval, and anagrelide may add to it. The combination may raise the risk of arrhythmia, particularly in patients with cardiac disease or electrolyte abnormalities.

How serious is the interaction between Anagrelide and Osimertinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if feasible. If used together, obtain periodic ECGs and electrolytes and correct abnormalities.

What other medicines interact with Anagrelide?

MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in